CSS LLC’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-40,400
| Closed | -$3.43M | – | 861 |
|
|
2019
Q4 | $3.43M | Buy |
40,400
+6,000
| +17% | +$400K | 0.19% | 106 |
|
|
2019
Q3 | $1.72M | Sell |
34,400
-19,200
| -36% | -$766K | 0.11% | 153 |
|
|
2019
Q2 | $1.95M | Buy |
53,600
+28,900
| +117% | +$943K | 0.11% | 148 |
|
|
2019
Q1 | $691K | Sell |
24,700
-3,100
| -11% | -$73.1K | 0.04% | 261 |
|
|
2018
Q4 | $532K | Buy |
27,800
+2,100
| +8% | +$48.9K | 0.04% | 277 |
|
|
2018
Q3 | $769K | Buy |
25,700
+15,000
| +140% | +$565K | 0.03% | 252 |
|
|
2018
Q2 | $393K | Buy |
+10,700
| New | +$348K | 0.02% | 331 |
|
|
2017
Q2 | – | Sell |
-11,000
| Closed | -$538K | – | 718 |
|
|
2017
Q1 | $538K | Buy |
11,000
+8,000
| +267% | +$365K | 0.03% | 319 |
|
|
2016
Q4 | $102K | Sell |
3,000
-5,000
| -63% | -$177K | 0.01% | 609 |
|
|
2016
Q3 | $302K | Sell |
8,000
-12,700
| -61% | -$479K | 0.01% | 477 |
|
|
2016
Q2 | $696K | Buy |
20,700
+5,000
| +32% | +$176K | 0.05% | 289 |
|
|
2016
Q1 | $499K | Buy |
+15,700
| New | +$513K | 0.03% | 340 |
|
|
2015
Q4 | – | Sell |
-2,500
| Closed | -$95K | – | 793 |
|
|
2015
Q3 | $95K | Buy |
+2,500
| New | +$87.8K | 0.01% | 673 |
|
Other funds holding MDCO
CSS LLC's MDCO Position: Q1 2020 in Review
CSS LLC sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 22,000 shares — an estimated $1.87M sold.
CSS LLC first reported a position in MDCO in Q4 2018 and held it in 2 quarters. The position peaked at $1.87M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- CSS LLC reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- CSS LLC sold 22,000 Medicines Co shares in Q1 2020, an estimated $1.87M.
- CSS LLC first reported a position in Medicines Co in Q4 2018 and held it in 2 quarters.
- CSS LLC's Medicines Co position peaked at $1.87M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on CSS LLC's 13F filing for Q1 2020, filed 15 May 2020.